Institutional Variation in Quality of Cardiovascular Implantable Electronic Device Implantation A Cohort Study

被引:30
|
作者
Ranasinghe, Isuru [1 ,2 ,11 ]
Labrosciano, Clementine [3 ,11 ]
Horton, Dennis [1 ,4 ,11 ]
Ganesan, Anand [5 ,6 ]
Curtis, Jeptha P. [7 ,8 ,12 ]
Krumholz, Harlan M. [9 ,10 ,12 ]
McGavigan, Andrew [5 ,6 ]
Hossain, Sadia [1 ,11 ]
Air, Tracy [3 ,11 ]
Hariharaputhiran, Saranya [1 ,11 ]
机构
[1] Univ Adelaide, Basil Hetzel Inst Translat Res, Adelaide, SA, Australia
[2] Cent Adelaide Local Hlth Network, Adelaide, SA, Australia
[3] Univ Adelaide, Adelaide, SA, Australia
[4] Data Decis Cooperat Res Ctr, Adelaide, SA, Australia
[5] Flinders Univ S Australia, Adelaide, SA, Australia
[6] Flinders Med Ctr, Adelaide, SA, Australia
[7] Yale New Haven Med Ctr, 20 York St, New Haven, CT 06504 USA
[8] Yale Sch Med, New Haven, CT USA
[9] Yale Sch Med, Yale New Haven Hosp, New Haven, CT USA
[10] Yale Univ, New Haven, CT USA
[11] Basil Hetzel Inst, DX 465701,28 Woodville Rd, Woodville South, SA 5011, Australia
[12] Ctr Outcomes Res & Evaluat, 1 Church St,Suite 200, New Haven, CT 06510 USA
关键词
CARDIOVERTER-DEFIBRILLATOR IMPLANTATION; COMPLICATIONS; PACEMAKER; RISK; MORTALITY; SAFETY; VOLUME;
D O I
10.7326/M18-2810
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cardiovascular implantable electronic devices (CIEDs) are associated with procedure-related complications, yet little is known about variation in complication rates among institutions that may suggest disparities in care quality. Objective: To assess institutional variation in risk-standardized complication rates (RSCRs) for CIED. Design: Cohort study. Setting: 174 hospitals in Australia and New Zealand, 98 of which implanted at least 25 CIEDs during the study period. Participants: 81 304 patients older than 18 years (mean, 74.7 years [SD, 12.4]; 37.9% female) who received a new CIED (65 711 permanent pacemakers [PPMs] and 15 593 implantable cardioverter-defibrillators [ICDs]) in 2010 to 2015. Measurements: RSCRs and frequencies of major device-related complications during hospitalization or within 90 days of discharge. Results: Of the cohort, 6664 patients (8.2%) had a major complication. Although complication rates were higher for ICDs than PPMs (10.04% vs. 7.76%), 76.5% of all complications were attributable to PPMs (5098 vs. 1566 for ICDs). Among hospitals that implanted at least 25 CIEDs, the median RSCR was 8.1%; how-ever, rates varied from 5.3% to 14.3%, with 22 hospitals identified as having RSCRs that differed significantly from the national average. Similar variation was observed when RSCRs for PPM implantation (n = 96 hospitals) (median RSCR, 7.6% [range, 5.4% to 12.9%]) were considered separately from those for ICD placement (n = 68 hospitals) (median RSCR, 9.7% [range, 6.2% to 16.9%]) and persisted when only elective procedures were assessed (n = 88 hospitals) (median RSCR, 7.4% [range, 4.7% to 13.0%]). Limitation: Possible unmeasured confounding from the use of administrative data. Conclusion: CIED complications are common and vary among hospitals, suggesting institutional variation in CIED care quality. Concerted clinical and policy interventions are needed to address CIED-related complications. These efforts should preferentially target PPMs, because most CIED complications are attributable to these devices.
引用
收藏
页码:309 / +
页数:10
相关论文
共 50 条
  • [1] Institutional Variation in Quality of Cardiovascular Implantable Electronic Device Implantation RESPONSE
    Ranasinghe, Isuru
    Hossain, Sadia
    Ganesan, Anand
    Krumholz, Harlan M.
    McGavigan, Andrew
    ANNALS OF INTERNAL MEDICINE, 2020, 172 (02) : 166 - 167
  • [2] Preoperative antibiotics and cardiovascular implantable electronic device infection: A cohort study in veterans
    Alzahrani, Talal
    Liappis, Angelike P.
    Baddour, Larry M.
    Karasik, Pamela E.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2018, 41 (11): : 1513 - 1518
  • [3] Variation in regional implantation patterns of cardiac implantable electronic device in Switzerland
    Bolt, Lucy
    Wertli, Maria M.
    Haynes, Alan G.
    Rodondi, Nicolas
    Chiolero, Arnaud
    Panczak, Radoslaw
    Aujesky, Drahomir
    PLOS ONE, 2022, 17 (02):
  • [4] Cardiovascular Implantable Electronic Device Surgery Following Left Ventricular Assist Device Implantation
    Black-Maier, Eric
    Lewis, Robert K.
    Loungani, Rahul
    Rehorn, Michael
    Friedman, Daniel J.
    Bishawi, Muath
    Schroder, Jacob N.
    Milano, Carmelo A.
    Katz, Jason N.
    Patel, Chetan B.
    Rogers, Joseph G.
    Hegland, Donald D.
    Jackson, Kevin P.
    Frazier-Mills, Camille
    Pokorney, Sean D.
    Daubert, James P.
    Piccini, Jonathan P.
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2020, 6 (09) : 1131 - 1139
  • [5] Cardiovascular Implantable Electronic Device Implantation with Uninterrupted Dabigatran: Comparison to Uninterrupted Warfarin
    Jennings, John M.
    Robichaux, Robert
    Mcelderry, H. Thomas
    Plumb, Vance J.
    Gunter, Alicia
    Doppalapudi, Harish
    Osorio, Jose
    Yamada, Takumi
    Kay, G. Neal
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2013, 24 (10) : 1125 - 1129
  • [6] The Burden and Risk Factors for Infection of Transvenous Cardiovascular Implantable Electronic Device: a Nationwide Cohort Study
    Yang, Pil-Sung
    Jeong, Jaehan
    You, So-Jeong
    Yu, Hee Tae
    Kim, Tae-Hoon
    Sung, Jung-Hoon
    Lee, Sang-Soo
    Park, Hyung-Deuk
    Joung, Boyoung
    KOREAN CIRCULATION JOURNAL, 2019, 49 (08) : 742 - 752
  • [7] Infections and associated costs following cardiovascular implantable electronic device implantations: a nationwide cohort study
    Clementy, Nicolas
    Carion, Phuong Lien
    de Leotoing, Lucie
    Lamarsalle, Ludovic
    Wilquin-Bequet, Fanny
    Brown, Benedict
    Verhees, Koen J. P.
    Fernandes, Jerome
    Deharo, Jean-Claude
    EUROPACE, 2018, 20 (12): : 1974 - 1980
  • [8] Statin use and the risk of cardiovascular implantable electronic device infection: A cohort study in a veteran population
    Alzahrani, Talal
    Liappis, Angelike P.
    Baddour, Larry M.
    Karasik, Pamela E.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2018, 41 (03): : 284 - 289
  • [9] Cardiovascular Implantable Electronic Device Infections
    Arnold, Christopher J.
    Chu, Vivian H.
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2018, 32 (04) : 811 - +
  • [10] Infective endocarditis and risk of death after cardiac implantable electronic device implantation: a nationwide cohort study
    Ozcan, Cengiz
    Raunso, Jakob
    Lamberts, Morten
    Kober, Lars
    Lindhardt, Tommi Bo
    Bruun, Niels Eske
    Laursen, Marie Louise
    Torp-Pedersen, Christian
    Gislason, Gunnar Hilmar
    Hansen, Morten Lock
    EUROPACE, 2017, 19 (06): : 1007 - 1014